Using AI and Natural Language Processing To Identify Postpartum Women with PTSD Related to Childbirth
Establishing noninvasive and low-cost data collection based on childbirth narratives for the identification of women with CB-PTSD could serve as an important first step to complement more extensive methods.
In Women with Bipolar Disorder, Loss of Sleep Related to Childbirth Increases Risk for Postpartum Psychosis
Loss of at least one night’s sleep at the time of labor and delivery is a potent risk factor for postpartum psychosis in women with bipolar disorder.
Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated
There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.
Resource: Check Out the Provider Directory from Postpartum Support International
We at the Center for Women's Mental Health rely so much upon Postpartum Support International. The organization helps women with perinatal mood and anxiety disorders to find specialized treatment all over the world. The PSI Provider Directory focuses specifically on connecting Perinatal Mental Health Professionals with those that are seeking [...]
Weekly Roundup for April 5, 2024: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Maternal Depression Negatively Affects Fetal Growth During Critical Stage of Development
In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.
Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
Increasing Rates of Maternal Mortality: How Do Overdose Deaths Contribute?
Between 2018 and 2021, pregnancy-associated overdose mortality rates increased among all women in all age groups, tripling in women between the ages of 35 and 44.